5/14
10:30 am
jazz
Groundbreaking Data Collection Platform opens to accelerate research in Central Disorders of Hypersomnolence [Yahoo! Finance]
Low
Report
Groundbreaking Data Collection Platform opens to accelerate research in Central Disorders of Hypersomnolence [Yahoo! Finance]
5/13
03:38 pm
jazz
Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA [Seeking Alpha]
Neutral
Report
Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA [Seeking Alpha]
5/13
03:07 am
jazz
Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases [Yahoo! Finance]
Medium
Report
Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases [Yahoo! Finance]
5/10
03:33 pm
jazz
Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug [Seeking Alpha]
Low
Report
Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug [Seeking Alpha]
5/7
11:13 am
jazz
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
05:10 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Medium
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
5/3
11:23 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $230.00 to $200.00. They now have an "overweight" rating on the stock.
5/3
06:48 am
jazz
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
5/2
11:04 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
5/2
08:11 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $222.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $222.00 price target on the stock.
5/1
08:31 pm
jazz
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Low
Report
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
5/1
04:21 pm
jazz
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance [Yahoo! Finance]
5/1
04:10 pm
jazz
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
Low
Report
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
5/1
04:10 pm
jazz
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
Low
Report
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
5/1
04:05 pm
jazz
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Low
Report
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
5/1
04:05 pm
jazz
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Low
Report
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
4/29
10:49 am
jazz
SUNOSI: A Dual-Acting Dopamine and Norepinephrine Reuptake Inhibitor (DNRI) for Obstructive sleep apnea (OSA) in 6MM - Market Size, Forecast, and Market Insights 2019-2032 [Yahoo! Finance]
Low
Report
SUNOSI: A Dual-Acting Dopamine and Norepinephrine Reuptake Inhibitor (DNRI) for Obstructive sleep apnea (OSA) in 6MM - Market Size, Forecast, and Market Insights 2019-2032 [Yahoo! Finance]
4/24
04:14 pm
jazz
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 [Yahoo! Finance]
4/24
04:05 pm
jazz
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
Low
Report
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
4/24
11:23 am
jazz
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]
4/23
11:31 am
jazz
Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community [Yahoo! Finance]
4/17
04:15 pm
jazz
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
Medium
Report
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
4/17
04:15 pm
jazz
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
Medium
Report
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
4/16
05:12 am
jazz
Acute Lymphocytic Leukemia (ALL) Pipeline Landscape Report 2024: Comprehensive Insights About 250+ Companies and 250+ Pipeline Drugs [Yahoo! Finance]
Low
Report
Acute Lymphocytic Leukemia (ALL) Pipeline Landscape Report 2024: Comprehensive Insights About 250+ Companies and 250+ Pipeline Drugs [Yahoo! Finance]
4/15
04:39 am
jazz
Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off [Seeking Alpha]
Medium
Report
Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off [Seeking Alpha]